EUVIMEDEUVIMED entdecken
Crossref

Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis

Rong Fu iD, Afroditi Boulougoura iD, Shuilian Yu, Hao Li, Wenliang Pan, Yushiro Endo, Rhea Bhargava iD, Abhiyan Satyam, Vivek Kasinath, Jarrat Jordan iD, Nandan Padmanabha, Maria G Tsokos und 2 weitere

Arthritis & Rheumatology · 2026-03 · 78 (3) · 672-683

DOI: 10.1002/art.43395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 30.12.2025. Verfasst von Rong Fu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Lupus Nephritis, Podocytes, Receptors, Interleukin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Janssen Pharmaceuticals, NIH HHS, Janssen Pharmaceutica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Up‐regulation of interleukin‐23 (IL‐23) in the serum and kidneys of patients with lupus nephritis (LN) has been demonstrated, but its effect on podocytes remains unknown. We hypothesized that IL‐23 contributes to podocyte injury and that targeted deletion of IL‐23 receptor (IL‐23R) in podocytes of lupus‐prone mice can prevent the development of glomerulonephritis.

Methods

Kidney biopsies were immunostained for IL‐23R. In vitro experiments were conducted using a human podocyte cell line and primary murine podocytes. Human podocytes stimulated with IL‐23 underwent bulk RNA sequencing. The expression of IL‐23R and structure and motility of podocytes were assessed. Podocytes isolated from B6 wild‐type mice injected with a minicircle (MC) encoding IL‐23 were studied. To assess the role of IL‐23R in the development of nephritis, we generated MRL/ lpr mice deficient in podocyte‐specific Il23r who were lupus prone.

Results

IL‐23R was highly expressed in the glomeruli of patients with LN. IL‐23R expression was also up‐regulated in human podocytes and primary podocytes isolated from B6 mice after IL‐23 stimulation. Human podocytes stimulated with IL‐23 showed decreased expression of synaptopodin and remodeling of the actin cytoskeleton. Mice who were administered with IL‐23 MC mice exhibited a significant increase in the expression of IL‐23R and phosphorylated STAT3 in podocytes. Finally, MRL/ lpr .Podo‐Cre + Il23r fl/fl mice showed decreased clinical and histologic features of LN.

Conclusion

IL‐23R expression is increased in podocytes from mice and humans with systemic lupus erythematosus. IL‐23 signaling disrupts the cytoskeleton in podocytes and increases their mobility, leading to the development of glomerulonephritis. Podocyte‐specific deletion of Il23r in lupus‐prone mice abrogates the development of LN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisPodocytesReceptors, InterleukinAnimalsHumansSignal TransductionMiceMice, Inbred MRL lprInterleukin-23STAT3 Transcription FactorFemaleKidney GlomerulusDisease Models, AnimalUp-Regulation

Substanzen

Receptors, InterleukinIL23R protein, humanInterleukin-23interleukin-23 receptor, mouseSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Janssen Pharmaceuticals, Spring House, Pennsylvania.
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: Rong Fu, Afroditi Boulougoura, Rhea Bhargava, Jarrat Jordan, George C Tsokos

Förderung

  • Janssen Pharmaceuticals
  • NIH HHS
  • Janssen Pharmaceutica
  • National Institutes of Health

Zitieren

APA

Fu, R., Boulougoura, A., Yu, S., Li, H., Pan, W., Endo, Y., Bhargava, R., Satyam, A., Kasinath, V., Jordan, J., Padmanabha, N., Tsokos, M. G., Abdi, R., & Tsokos, G. C. (2026). Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis. Arthritis & Rheumatology, 78(3), 672-683. https://doi.org/10.1002/art.43395

Vancouver

Fu R, Boulougoura A, Yu S, Li H, Pan W, Endo Y, et al. Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis. Arthritis & Rheumatology. 2026;78(3):672-683. doi:10.1002/art.43395

BibTeX
@article{Fu2026,
  author = {Fu, Rong and Boulougoura, Afroditi and Yu, Shuilian and Li, Hao and Pan, Wenliang and Endo, Yushiro and Bhargava, Rhea and Satyam, Abhiyan and Kasinath, Vivek and Jordan, Jarrat and Padmanabha, Nandan and Tsokos, Maria G and Abdi, Reza and Tsokos, George C},
  title = {Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  volume = {78},
  number = {3},
  pages = {672--683},
  doi = {10.1002/art.43395}
}
Kostenlos starten →